Alert detail
FDA Approval: LUMVOA (VELIGROTUG-VVZE) — Type 1 - New Molecular Entity
Policy ID: FDA-BLA761530Specialty: OphthalmologyAdded: 7/2/2026Effective: 2026-06-26billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.